Lastly, to determine if this was a melanoma-specific myeloid response, we treated mice bearing syngeneic pancreatic68 or breast tumors69 (that express similar or higher levels of CD47 compared to B16.F10 cells, Figure S5D) using the same treatment regimen. The gene discussed is CD47; the disease is melanoma.